European equities traded in the US as American depositary receipts were higher late Monday morning, rising 0.2% to 1,527.9 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by medical device maker EDAP TMS (EDAP) and internet browser company Opera (OPRA), which advanced 6.8% and 4% respectively. They were followed by biopharmaceutical company Cellectis (CLLS) and biotech firm Evaxion (EVAX), which rose 2.2% and 2% respectively.

The decliners from continental Europe were led by biotech company BioNTech (BNTX) and brewing company Anheuser-Busch InBev (BUD), which dropped 5.1% and 1.4% respectively. They were followed by pharmaceutical company Novo Nordisk (NVO) and telecommunications company Ericsson (ERIC), which fell 1.2% and 1% respectively.

From the UK and Ireland, the gainers were led by biopharmaceutical company Adaptimmune Therapeutics (ADAP) and hospitality company InterContinental Hotels Group (IHG), which increased 5.9% and 1.3% respectively. They were followed by financial services company Barclays (BCS) and cruise line operator Carnival (CUK), which were up 1.2% each.

The decliners from the UK and Ireland were led by biopharmaceutical company Biodexa Pharmaceuticals (BDRX) and biotech company Trinity Biotech (TRIB), which lost 6.2% and 4.3% respectively. They were followed by pharmaceutical company Silence Therapeutics (SLN) and alcoholic beverage company Diageo (DEO), which were down 3.3% and 3% respectively.